FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280615055> ?p ?o ?g. }

• W4280615055 endingPage "6" @default.
• W4280615055 startingPage "1" @default.
• W4280615055 abstract "The study is aimed at evaluating the immune-activation state before and after treatment in patients with first-episode depressive disorder (FDD) with evaluating the ILs and CRP levels and further clarifying the association between autoimmunity and the etiology and pathogenesis of FDD.We designed a case-control study. FDD patients and healthy subjects were enrolled in the FDD group and control group. Serum IL-6, IL-17, and CRP were measured before and after selective serotonin reuptake inhibitor (SSRI) therapy, as well as Hamilton rating scale for depression (HAMD) and life event scale (LES) scores. The correlations between IL-6 and IL-17 and HAMD and LES scores were analysed, and multiple linear regression analysis was performed for HAMD score.40 FDD patients and 40 healthy subjects were included in the FDD and control group from October 2009 to September 2012. Before treatment, the IL-6 (28.99 ± 5.51, P < 0.001) and IL-17 (41.15 ± 4.80, P < 0.001) in the FDD group were significantly higher than the control group (16.84 ± 3.78 and 21.68 ± 3.72, respectively). The C-reactive protein (CRP) level in two groups was comparable (P = 0.879). After treatment, the IL-6 (18.69 ± 5.07, P < 0.001) and IL-17 (30.67 ± 3.47, P < 0.001) levels and HAMD scores (6.73 ± 4.15) in the FDD group were significantly decreased than before treatment (P < 0.001, respectively). CRP level was slightly increased after treatment without statistically significant (P = 0.239). The HAMD score correlated with IL-6 (r = 0.638, P < 0.001) and IL-17 (r = 0.927, P < 0.001); the total LES and negative LES also correlated with IL-6 (r = 0.226, P < 0.05) (r = 0.366, P <0.001) and IL-17 (r = 0.348, P < 0.001) (r = 0.493, P < 0.001). Multiple linear regression analysis showed that both of the IL-6 and IL-17 had direct impact on HAMD score.The autoimmunity status was overactivated in FDD patients, and serum IL-6 and IL-17 levels had direct impact on the HAMD score. Patients who experienced more negative life events had higher activation level of autoimmunity status and HAMD scores, and serum IL-6 and IL-17 levels can be decreased by SSRI treatment." @default.
• W4280615055 created "2022-05-22" @default.
• W4280615055 creator A5006822602 @default.
• W4280615055 creator A5049151983 @default.
• W4280615055 creator A5052979295 @default.
• W4280615055 creator A5085147152 @default.
• W4280615055 date "2022-05-16" @default.
• W4280615055 modified "2023-10-01" @default.
• W4280615055 title "Associations between Autoimmunity and Depression: Serum IL-6 and IL-17 Have Directly Impact on the HAMD Scores in Patients with First-Episode Depressive Disorder" @default.
• W4280615055 cites W1964368905 @default.
• W4280615055 cites W1979229771 @default.
• W4280615055 cites W1986688198 @default.
• W4280615055 cites W1988193674 @default.
• W4280615055 cites W2032123560 @default.
• W4280615055 cites W2156150528 @default.
• W4280615055 cites W2192342554 @default.
• W4280615055 cites W2407171739 @default.
• W4280615055 cites W2519531315 @default.
• W4280615055 cites W2572054206 @default.
• W4280615055 cites W2581084710 @default.
• W4280615055 cites W2587663472 @default.
• W4280615055 cites W2590599688 @default.
• W4280615055 cites W2590668924 @default.
• W4280615055 cites W2606383554 @default.
• W4280615055 cites W2624985772 @default.
• W4280615055 cites W2811106610 @default.
• W4280615055 cites W2886676544 @default.
• W4280615055 cites W2895789699 @default.
• W4280615055 cites W2898061534 @default.
• W4280615055 cites W2912280329 @default.
• W4280615055 cites W2921569358 @default.
• W4280615055 cites W2934413595 @default.
• W4280615055 cites W2939946042 @default.
• W4280615055 cites W2979595541 @default.
• W4280615055 cites W2990456109 @default.
• W4280615055 cites W3012729670 @default.
• W4280615055 cites W3046493738 @default.
• W4280615055 cites W3092209564 @default.
• W4280615055 doi "https://doi.org/10.1155/2022/6724881" @default.
• W4280615055 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35615531" @default.
• W4280615055 hasPublicationYear "2022" @default.
• W4280615055 type Work @default.
• W4280615055 citedByCount "9" @default.
• W4280615055 countsByYear W42806150552023 @default.
• W4280615055 crossrefType "journal-article" @default.
• W4280615055 hasAuthorship W4280615055A5006822602 @default.
• W4280615055 hasAuthorship W4280615055A5049151983 @default.
• W4280615055 hasAuthorship W4280615055A5052979295 @default.
• W4280615055 hasAuthorship W4280615055A5085147152 @default.
• W4280615055 hasBestOaLocation W42806150551 @default.
• W4280615055 hasConcept C126322002 @default.
• W4280615055 hasConcept C137627325 @default.
• W4280615055 hasConcept C138496976 @default.
• W4280615055 hasConcept C139719470 @default.
• W4280615055 hasConcept C15744967 @default.
• W4280615055 hasConcept C162324750 @default.
• W4280615055 hasConcept C2776867660 @default.
• W4280615055 hasConcept C2777198177 @default.
• W4280615055 hasConcept C2779144063 @default.
• W4280615055 hasConcept C2780051608 @default.
• W4280615055 hasConcept C2780942790 @default.
• W4280615055 hasConcept C2993089816 @default.
• W4280615055 hasConcept C3018023364 @default.
• W4280615055 hasConcept C71924100 @default.
• W4280615055 hasConcept C83849319 @default.
• W4280615055 hasConcept C90924648 @default.
• W4280615055 hasConceptScore W4280615055C126322002 @default.
• W4280615055 hasConceptScore W4280615055C137627325 @default.
• W4280615055 hasConceptScore W4280615055C138496976 @default.
• W4280615055 hasConceptScore W4280615055C139719470 @default.
• W4280615055 hasConceptScore W4280615055C15744967 @default.
• W4280615055 hasConceptScore W4280615055C162324750 @default.
• W4280615055 hasConceptScore W4280615055C2776867660 @default.
• W4280615055 hasConceptScore W4280615055C2777198177 @default.
• W4280615055 hasConceptScore W4280615055C2779144063 @default.
• W4280615055 hasConceptScore W4280615055C2780051608 @default.
• W4280615055 hasConceptScore W4280615055C2780942790 @default.
• W4280615055 hasConceptScore W4280615055C2993089816 @default.
• W4280615055 hasConceptScore W4280615055C3018023364 @default.
• W4280615055 hasConceptScore W4280615055C71924100 @default.
• W4280615055 hasConceptScore W4280615055C83849319 @default.
• W4280615055 hasConceptScore W4280615055C90924648 @default.
• W4280615055 hasLocation W42806150551 @default.
• W4280615055 hasLocation W42806150552 @default.
• W4280615055 hasLocation W42806150553 @default.
• W4280615055 hasOpenAccess W4280615055 @default.
• W4280615055 hasPrimaryLocation W42806150551 @default.
• W4280615055 hasRelatedWork W2359456137 @default.
• W4280615055 hasRelatedWork W2378996837 @default.
• W4280615055 hasRelatedWork W2380708610 @default.
• W4280615055 hasRelatedWork W2383545306 @default.
• W4280615055 hasRelatedWork W2383699116 @default.
• W4280615055 hasRelatedWork W2383855066 @default.
• W4280615055 hasRelatedWork W2384194201 @default.
• W4280615055 hasRelatedWork W2384564872 @default.
• W4280615055 hasRelatedWork W3030130190 @default.
• W4280615055 hasRelatedWork W3030202538 @default.
• W4280615055 hasVolume "2022" @default.

• next